| Demirbas A, Hugo C, Grinyó J, et al.
Low toxicity regimens in renal transplantation: a country subset analysis of the Symphony study. [Journal Article, Research Support, Non-U.S. Gov't]
Transpl Int 2009 Dec; 22(12):1172-81.
Abstract | Full Citation |
| Otero A, Varo E, de Urbina JO, et al.
A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids. [JOURNAL ARTICLE]
Liver Transpl 2009 Oct 28; 15(11):1542-1552.
Abstract | Full Citation | Find Related Articles |
| Post M, Raszeja-Wyszomirska J, Jarosz K, et al.
Immunosuppression With Low-Dose Daclizumab in Liver Transplant Recipients With Impaired Kidney Function: A Single-Center Experience. [JOURNAL ARTICLE]
Transplant Proc 2009 Oct; 41(8):3107-3109.
Abstract | Full Citation |
| Foroncewicz B, Mucha K, Ryszkowska E, et al.
Safety and Efficacy of Steroid-Free Immunosuppression with Tacrolimus and Daclizumab in Liver Transplant Recipients: 6-Year Follow-up in a Single Center. [JOURNAL ARTICLE]
Transplant Proc 2009 Oct; 41(8):3103-3106.
Abstract | Full Citation | Find Related Articles |
| Aull MJ, Suthanthiran M
Transplantation: Personalizing induction therapy in kidney transplantation. [Journal Article]
Nat Rev Nephrol 2009 Nov; 5(11):619-20.
Full Citation | Publisher Full Text | Find Related Articles |
| Grenda R
Effects of steroid avoidance and novel protocols on growth in paediatric renal transplant patients. [JOURNAL ARTICLE]
Pediatr Nephrol 2009 Oct 21.
Abstract | Full Citation |
| Rother KI, Spain LM, Wesley RA, et al.
Effects of Exenatide Alone and in Combination with Daclizumab on Beta Cell Function in Long-Standing Type 1 Diabetes Mellitus. [JOURNAL ARTICLE]
Diabetes Care 2009 Oct 6.
Abstract | Full Citation |
| Group TC
2007 Update on Allogeneic Islet Transplantation from the Collaborative Islet Transplant Registry (CITR). [JOURNAL ARTICLE]
Cell Transplant 2009 Sep 28.
Abstract | Full Citation | Find Related Articles |
| Monti P, Brigatti C, Heninger AK, et al.
Disengaging the IL-2 Receptor with Daclizumab Enhances IL-7-Mediated Proliferation of CD4(+) and CD8(+) T Cells. [JOURNAL ARTICLE]
Am J Transplant 2009 Sep 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Ju WQ, He XS, Tan YL, et al.
[Two-dose steroid combined with two-dose daclizumab and tacrolimus regimen in liver transplant recipients.] [English Abstract, Journal Article]
Zhonghua Wai Ke Za Zhi 2009 Jul 15; 47(14):1064-6.
Abstract | Full Citation | Find Related Articles |
  |
